Biologics

Asimov Launches New Cell Line Service, Expanding LV Edge System to Boost Therapeutic Production

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the la...

 April 29, 2024 | News

MiLaboratories and Miltenyi Biotec Forge Partnership to Advance Next-Generation Therapies

MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership...

 April 29, 2024 | News

AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology

  New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...

 April 23, 2024 | News

BGI Genomics Opens Cutting-Edge Clinical Laboratory in Uruguay to Advance Precision Medicine in Latin America

BGI Genomics, a global leader in integrated precision medicine solutions, has established a new clinical laboratory at Uruguay's Parque de las Ci...

 April 22, 2024 | News

Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment

Hyundai Bioscience CEO Oh Sang-gi,  announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...

 April 22, 2024 | News

Exyte Strengthens Global Presence with Kinetics Group Acquisition

Kinetics is a globally leading provider of installation services and equipment  Company serves high-tech industries such as semiconductor, biopharm...

 April 17, 2024 | News

Asahi Kasei Bioprocess and Axolabs Partner to Boost Oligonucleotide Therapy Development

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide ...

 April 12, 2024 | News

Thermo Fisher Scientific Launches Revolutionary Gibco™ CTS™ OpTmizer™ One SFM for Enhanced T Cell Therapy Production

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium&n...

 April 12, 2024 | News

Rising Prevalence of Inflammatory Bowel Disease in Developing Countries Signals Urgent Need for Innovative Treatments

IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China....

 April 11, 2024 | News

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...

 April 10, 2024 | News

BioCity Biopharma's Cancer Therapy BC2027 Gets FDA Nod for Phase 1 Trials

BioCity Biopharma announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Pha...

 April 10, 2024 | News

Celonic and Revvity Forge Strategic Alliance to Accelerate Monoclonal Antibodies and Complex Protein Development

 Celonic has signed a commercial license agreement with Revvity for its CHOSOURCE™ expression platform and TnT transposon technology. The R...

 April 09, 2024 | News

YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia

YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...

 April 03, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak  announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

 April 02, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close